Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,230 | 9 | 38.9% |
| Consulting Fee | $18,980 | 10 | 24.4% |
| Travel and Lodging | $12,356 | 33 | 15.9% |
| Food and Beverage | $11,460 | 468 | 14.8% |
| Honoraria | $3,890 | 4 | 5.0% |
| Education | $766.42 | 14 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $29,527 | 48 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $12,876 | 39 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $8,641 | 13 | $0 (2022) |
| GENZYME CORPORATION | $6,425 | 17 | $0 (2023) |
| PFIZER INC. | $3,918 | 102 | $0 (2023) |
| Hoffmann-La Roche Limited | $2,867 | 7 | $0 (2018) |
| Astellas Pharma Global Development | $2,241 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $1,860 | 43 | $0 (2023) |
| Seagen Inc. | $1,731 | 5 | $0 (2023) |
| AVEO Pharmaceuticals, Inc. | $1,137 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $884.35 | 33 | Sirtex Medical Inc ($274.82) |
| 2022 | $3,571 | 64 | Seagen Inc. ($1,696) |
| 2021 | $6,715 | 39 | Astellas Pharma Global Development ($2,241) |
| 2020 | $3,808 | 19 | Bayer HealthCare Pharmaceuticals Inc. ($1,844) |
| 2019 | $3,950 | 110 | Exelixis Inc. ($2,033) |
| 2018 | $24,281 | 116 | Exelixis Inc. ($11,251) |
| 2017 | $34,473 | 157 | Exelixis Inc. ($16,192) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 06/21/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: Oncology | ||||||
| 06/20/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: Oncology | ||||||
| 06/14/2023 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Oncology | ||||||
| 06/06/2023 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2023 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
| 05/30/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Oncology | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Oncology | ||||||
| 05/17/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/17/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Oncology | ||||||
| 05/16/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $125.70 | General |
| Category: Interventional Oncology | ||||||
| 05/09/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $149.12 | General |
| Category: Interventional Oncology | ||||||
| 04/19/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: Hematology/Oncology | ||||||
| 04/11/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.53 | General |
| 04/06/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Oncology | ||||||
| 03/28/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Oncology | ||||||
| 03/10/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Oncology | ||||||
| 03/07/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Oncology | ||||||
| 03/02/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 283 | 476 | $108,159 | $29,567 |
| 2022 | 4 | 718 | 1,412 | $351,822 | $102,531 |
| 2021 | 6 | 687 | 1,395 | $315,246 | $93,369 |
| 2020 | 8 | 825 | 1,772 | $308,727 | $86,567 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 144 | $37,460 | $10,161 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 120 | $31,345 | $8,850 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 113 | $20,971 | $5,505 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 99 | $18,384 | $5,051 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 377 | $100,544 | $29,801 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 188 | 370 | $98,710 | $29,045 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 254 | $48,518 | $13,128 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 88 | 215 | $40,857 | $10,981 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 84 | $31,819 | $9,400 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 56 | 64 | $24,243 | $7,296 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 48 | $7,131 | $2,881 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 283 | $76,670 | $23,054 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 116 | 258 | $69,897 | $20,399 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 144 | 319 | $60,935 | $16,524 | 27.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 300 | $57,306 | $15,607 | 27.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 153 | $22,917 | $9,057 | 39.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 44 | $16,682 | $5,385 | 32.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,307 | $1,752 | 33.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $4,246 | $1,285 | 30.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 11 | 11 | $1,285 | $305.80 | 23.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 198 | 575 | $90,559 | $23,148 | 25.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 93 | 254 | $38,795 | $15,342 | 39.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 117 | 235 | $53,672 | $14,166 | 26.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 141 | 313 | $49,287 | $13,070 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 116 | 185 | $42,143 | $11,318 | 26.9% |
About Dr. Alan Koletsky, MD
Dr. Alan Koletsky, MD is a Specialist healthcare provider based in Delray Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952359234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Koletsky, MD has received a total of $77,682 in payments from pharmaceutical and medical device companies, with $884.35 received in 2023. These payments were reported across 538 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,230).
As a Medicare-enrolled provider, Koletsky has provided services to 2,513 Medicare beneficiaries, totaling 5,055 services with total Medicare billing of $312,033. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine, Medical Oncology
- Location Delray Beach, FL
- Active Since 05/05/2006
- Last Updated 03/15/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1952359234
Products in Payments
- Cabometyx (Drug) $27,476
- OPDIVO (Biological) $12,817
- Xofigo (Drug) $8,577
- JEVTANA (Drug) $6,263
- BAVENCIO (Drug) $2,983
- PADCEV (Drug) $2,284
- Non-Covered Product (Drug) $1,921
- KEYTRUDA (Biological) $1,796
- PADCEV (Biological) $1,672
- TECENTRIQ (Biological) $1,291
- FOTIVDA (Drug) $1,137
- SIR-Spheres Microspheres (Device) $593.23
- ERLEADA (Drug) $512.08
- XTANDI (Drug) $427.43
- GILOTRIF (Drug) $254.20
- Erleada (Drug) $250.96
- Lenvima (Drug) $200.77
- IMFINZI (Drug) $178.33
- IMBRUVICA (Drug) $170.27
- ZEPZELCA (Drug) $153.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Delray Beach
Warren Brenner, M.d, M.D
Specialist — Payments: $256,934
Barry Kuttner, M.d., Ph.d, M.D., PH.D
Specialist — Payments: $170,130
Rodolfo Carrillo Jimenez, Md, MD
Specialist — Payments: $13,339
Alka Sawhney, M.d, M.D
Specialist — Payments: $12,481
Stephen Grabelsky, Md, MD
Specialist — Payments: $11,094
Hilary Gomolin, Md, MD
Specialist — Payments: $10,085